Moderna Develops Hybrid Vaccine for Omicron
Jakarta – Modern has initiated studies of booster vaccines incorporating formulations designed to fend off variants Omicron with vaccines COVID-19 which has existed. The first participants in the study have been given an experimental injection in a phase 2 study for the candidate Omicron-specific bivalent booster. This injection incorporates Moderna’s current COVID-19 vaccine. “We are … Read more